30.09.2022 • NewsArkemarenewable

Arkema Ups Expansion Plans for Pebax Elastomers

Arkema has boosted its previously announced expansion plans for Pebax elastomer at its Serquigny site in France. The company will now increase capacity by 40% rather than the 25% it announced in January this year.

The project will be undertaken in two separate phases. The first will raise output by 15% in the first quarter of 2023, then by a further 25% starting in the third quarter of next year.

In addition to the French expansion, Arkema said it is currently assessing further investment opportunities, including in Asia, in order to support the growth of its global customers in the sports, consumer electronics, medical and industrial markets. Applications range from running shoes and ski boots to catheters and to flexible device screens.

Arkema cited particularly strong growth for its bio-based Pebax grade called Rnew that is derived from renewable castor beans and can be fully recycled.

“We are very excited to announce this acceleration of our Pebax elastomer capacity increase. Demand continues to grow, especially for our bio-based Pebax Rnew range”, said Erwoan Pezron, senior vice president of Arkema’s high-performance polymers business. “There is no compromise between high performance and sustainability. Our customers demand both.”

Author: Elaine Burridge, Freelance Author

(c) Arkema
(c) Arkema

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read